In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia
(Q40716128)
scientific article published on July 2002
scientific article published on July 2002
Language:
Current Data About
In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia
other details
description | scientific article published on July 2002 |
External Links
(P356) |
10.1016/S0301-472X(02)00836-6
|
(P698) |
12135670
|